Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zanchetti

Showing results (171-180 of 197) with videos related to

Pageof 20
Sort By:
Journal of Hypertension|March 19, 2019
Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndromePatricio López-Jaramillo, Eduardo Barbosa, Dora I Molina, et al.
Journal of Hypertension|July 29, 2016
2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescentsEmpar Lurbe, Enrico Agabiti-Rosei, J Kennedy Cruickshank, et al.
JAMA|April 24, 2003
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trialHenry R Black, William J Elliott, Gregory Grandits, et al.
Journal of Hypertension|June 24, 2006
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trialSverre E Kjeldsen, Stevo Julius, Giuseppe Mancia, et al.
Journal of Hypertension|April 19, 2005
Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical regionHenry R Black, William J Elliott, Gregory Grandits, et al.
Hypertension (Dallas, Tex. : 1979)|February 24, 2001
Baseline Characteristics and Early Blood Pressure Control in the CONVINCE TrialHenry R. Black, William J. Elliott, James D. Neaton, et al.
Plos Medicine|March 21, 2018
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant dataKunal N Karmali, Donald M Lloyd-Jones, Joep van der Leeuw, et al.
JAMA Internal Medicine|September 6, 2017
Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysisRakesh Malhotra, Hoang Anh Nguyen, Oscar Benavente, et al.
Journal of Hypertension|October 21, 2006
Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trialAlberto Zanchetti, Stevo Julius, Sverre Kjeldsen, et al.
Journal of Hypertension|March 24, 2018
Isolated systolic hypertension in the young: a position paper endorsed by the European Society of HypertensionPaolo Palatini, Enrico Agabiti Rosei, Alberto Avolio, et al.
Pageof 20

Showing results (171-180 of 197) with videos related to

Sort By:
Pageof 20
Journal of Hypertension|March 19, 2019
Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndromePatricio López-Jaramillo, Eduardo Barbosa, Dora I Molina, et al.
Journal of Hypertension|July 29, 2016
2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescentsEmpar Lurbe, Enrico Agabiti-Rosei, J Kennedy Cruickshank, et al.
JAMA|April 24, 2003
Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trialHenry R Black, William J Elliott, Gregory Grandits, et al.
Journal of Hypertension|June 24, 2006
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trialSverre E Kjeldsen, Stevo Julius, Giuseppe Mancia, et al.
Journal of Hypertension|April 19, 2005
Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical regionHenry R Black, William J Elliott, Gregory Grandits, et al.
Hypertension (Dallas, Tex. : 1979)|February 24, 2001
Baseline Characteristics and Early Blood Pressure Control in the CONVINCE TrialHenry R. Black, William J. Elliott, James D. Neaton, et al.
Plos Medicine|March 21, 2018
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant dataKunal N Karmali, Donald M Lloyd-Jones, Joep van der Leeuw, et al.
JAMA Internal Medicine|September 6, 2017
Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysisRakesh Malhotra, Hoang Anh Nguyen, Oscar Benavente, et al.
Journal of Hypertension|October 21, 2006
Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trialAlberto Zanchetti, Stevo Julius, Sverre Kjeldsen, et al.
Journal of Hypertension|March 24, 2018
Isolated systolic hypertension in the young: a position paper endorsed by the European Society of HypertensionPaolo Palatini, Enrico Agabiti Rosei, Alberto Avolio, et al.
Pageof 20